A chitosan-xanthone-GO nanocomposite as a pH-sensitive nanocarrier for controlled release of the antitumor drug.
No takes yet. Share an insight, caveat, or question.
Cheng et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: